Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Share Price (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 974.80
Bid: 933.00
Ask: 1,044.00
Change: 0.00 (0.00%)
Spread: 111.00 (11.897%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 974.80
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smith & Nephew Plc Ord Usd0.20

Smith & Nephew is listed in the FTSE All-Share, FTSE 350 Low Yield, FTSE 350, FTSE 100 indices.

Smith & Nephew is listed in the Medical Services sector.

Smith & Nephew Plc Ord Usd0.20 is listed on the London Stock Exchange trading with ticker code SN..L. It has a market capitalisation of £8.52b, with approximately 874.33m shares in issue. Over the last year, Smith & Nephew share price has been traded in a range of 429.00, hitting a high of 1,316.00, and a low of 887.00.

Smith & Nephew is a global medical technology company headquartered in London, UK. Founded in 1856, the company specialises in developing and manufacturing medical devices and advanced wound care products. Smith & Nephew's products cater to various medical specialties, including orthopedics, sports medicine, and advanced wound management. Their offerings include joint replacement implants, arthroscopic equipment, wound dressings, and advanced wound care therapies. With a focus on innovation and patient outcomes, Smith & Nephew continues to be a leading provider of medical solutions that improve the quality of life for patients worldwide.

Smith & Nephew Share Price
Price 974.80
Bid 933.00
Ask 1,044.00
Change 0.00 (0.00%)
Volume 0
Open 0.00
High 0.00
Low 0.00
Prev. Close 974.80
Currency GBX
Issue Country GB
Shares in Issue 874.33m
Market Capitalisation £8.52b
Market Size 2,000
52 Week High 1,316.00
52 Week High Date 02-May-2023
52 Week Low 887.00
52 Week Low Date 27-Oct-2023
# Trades 0
Vol. Sold 0
Sold Value £N/A
Vol. Bought 0
Bought Value £N/A
PE Ratio 41.09635
Earnings 23.71987
Dividend 30.27
Yield 3.105%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Smith & Nephew (SN.)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
22-Apr-2418:08:55972.95617,675Unknown*977.60977.80171.97kO Ordinary
Was reported as OTC
22-Apr-2418:08:09973.117,610Unknown*977.60977.8074.05kO Ordinary
Was reported as OTC
22-Apr-2418:07:27972.87434,064Unknown*977.60977.80331.40kO Ordinary
Was reported as OTC
22-Apr-2418:06:26974.80135Unknown*977.60977.801,316O Ordinary
Was reported as OTC
22-Apr-2418:05:04974.7842,257Unknown*977.60977.8022.00kO Ordinary
Was reported as OTC
22-Apr-2418:04:13972.08347Unknown*977.60977.803,373O Ordinary
Was reported as OTC
22-Apr-2418:04:13974.8025,701Unknown*977.60977.80250.53kO Ordinary
Was reported as OTC
22-Apr-2418:04:13974.8026,351Unknown*977.60977.80256.87kO Ordinary
Was reported as OTC
22-Apr-2417:46:38976.698524Unknown*977.60977.805,118O Ordinary
Was reported as OTC
22-Apr-2417:46:38976.182,245Unknown*977.60977.8021.92kO Ordinary
Was reported as OTC

Directors Deals for Smith & Nephew (SN.)

Announced Traded Action Notifier Price Currency Amount Holding
17-Jan-2409-Jan-24BuyDeepak Nath held the position of CEO at the time of this trade.Deepak Nath23.19USD408107,222
14-Nov-2313-Nov-23SellDeepak Nath held the position of CEO at the time of this trade.Deepak Nath1,001.09GBX1,961106,814
14-Nov-2313-Nov-23Transfer FromDeepak Nath held the position of CEO at the time of this trade.Deepak Nath0.004,788106,814
10-Nov-2310-Nov-23BuyJeremy (Jez) Maiden held the position of Independent Non-Executive Director at the time of this trade.Jeremy (Jez) Maiden1,007.75GBX1,0001,000
10-Nov-2308-Nov-23SellDeepak Nath held the position of CEO at the time of this trade.Deepak Nath987.80GBX1,771103,987
Smith & Nephew

Smith+Nephew is a portfolio medical device company focused on the repair, regeneration and replacement of soft and hard tissue.

Smith & Nephew Home Page

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.